COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target raised by analysts at JPMorgan Chase & Co. from $19.00 to $21.00. They now have an "overweight" rating on the stock.
Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting
Form SC 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Form SC 13G/A Cogent Biosciences, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.
Form SC 13G/A Cogent Biosciences, Inc. Filed by: COMMODORE CAPITAL LP
Form SC 13G/A Cogent Biosciences, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Form SC 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.